Search

Search Constraints

You searched for: Author/Creator Poulakou, Garyfallia

Search Results

1. 1153. Safety and Potential Efficacy of Exosomes Overexpressing CD24 (EXO-CD24) for the Prevention of Clinical Deterioration in Patients with Moderate or Severe COVID-19: A Phase II, Randomized, Single-blinded Study. (15th December 2022)

4. De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock. (31st August 2020)

5. De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock. (31st August 2020)

6. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis. (October 2021)

7. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial. Issue 10324 (5th February 2022)

8. Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia. (February 2023)

9. Nebulization of Antiinfective Agents in Invasively Mechanically Ventilated Adults: A Systematic Review and Meta-analysis. (May 2017)

10. Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial. Issue 1 (3rd November 2022)